MRC Technology and Biocartis initiate development of liquid biopsy test for breast cancer

08-Jun-2017 - MRC Technology and Biocartis Group NV announced a partnership to develop selected molecular diagnostic tests for use on Biocartis' fully automated Idylla(TM) platform. MRCT aims to move promising medical research forward into patient treatments and diagnostics and has been involved in helping ...

Biocartis announces its new CEO

10-May-2017 - Biocartis Group announces Herman Verrelst as its new Chief Executive Officer (CEO), effective as of August 2017. Herman is a seasoned executive and serial entrepreneur with a proven international commercial track-record in molecular diagnostics. Herman currently holds the position of Vice ...

Merck and Biocartis to Collaborate

08-Jan-2016 - Merck announced that it has signed a collaboration agreement with Biocartis for the development and commercialization of a new liquid biopsy RAS biomarker test for patients with metastatic colorectal cancer (mCRC). The test will be developed on Biocartis’ innovative, fully automated molecular ...

Biocartis and Fast-track diagnostics sign strategic collaboration in infectious diseases

28-May-2015 - Biocartis and Fast-track diagnostics announced that they have entered into a strategic collaboration to develop a range of multiplex infectious disease tests to run on the Biocartis Idylla™ system.Biocartis and Fast-track diagnostics plan to collaborate on a new approach to infectious disease ...

Biocartis to develop Rapid Ebola Virus Triage Test

11-Feb-2015 - Biocartis announces that it is in the testing phase of a Rapid Ebola Virus Triage Test that it is developing in association with Janssen Diagnostics and the Institute for Tropical Medicine in Antwerp (Belgium) for its Idylla™system. The Rapid Ebola Virus Triage Test is designed to enable ...

BioCartis receives € 1,7M IWT grant for improved disease diagnosis

30-Jun-2014 - Biocartis announced it received a grant of € 1.7M from the Flemish Government to further enhance the capabilities of its flagship platform Idylla™. With this grant the Flemish Agency for Innovation by Science andTechnology (IWT) affirms its belief in Biocartis’ cutting edge R&D. Biocartis will ...

Biocartis strengthens management team with general counsel

18-Jan-2013 - Biocartis announced that Inge Basteleurs has joined the company as General Counsel. Inge will be a member of Biocartis’ Executive Committee and a director of Biocartis NV. Inge Basteleurs brings to Biocartis a 17-year career as a senior international executive within the biotechnology and ...

Biocartis collaborates with Philips and Wellcome Trust in oncology diagnostics

Collaboration to develop an automated blood based assay-system for monitoring tumor load

30-May-2012 - Biocartis announces that its researchers, in collaboration with researchers at the Wellcome Trust Sanger Institute and at Philips Research, are developing a novel workflow for extraction and amplification & detection of tumor DNA on Biocartis diagnostic platforms. Biocartis retains its full IP ...

Biocartis appoints Clark Harrison as Chief Operating Officer

12-Jan-2012 - Biocartis announced the appointment of Clark Harrison as its new Chief Operating Officer. Clark is the first senior appointment following the announcement of new CEO Greg Parekh.Parekh’s move to add Clark to his top management team, marks a new phase for the company as it strengthens production ...

Biocartis names Dr. Nayan Gregory Parekh as CEO

Current ceo rudi pauwels becomes executive chairman focusing on scientific and technology strategy

02-Dec-2011 - Biocartis announced the appointment of Dr. Nayan Gregory Parekh as its new Chief Executive Officer.Parekh brings to Biocartis a wealth of pharmaceutical and biotechnology industry experience and has been an Executive Director of the Company’s Board since April 2011. Rudi Pauwels, co-founder of ...